URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ann Falsey

Concepts (303)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Respiratory Syncytial Virus Infections
36
1995
121
10.980
Why?
Respiratory Tract Infections
22
1990
150
6.460
Why?
Antibodies, Viral
25
1990
472
4.810
Why?
Respiratory Syncytial Virus, Human
16
1997
53
4.780
Why?
Metapneumovirus
10
2003
19
4.530
Why?
Paramyxoviridae Infections
12
1991
34
4.520
Why?
Influenza, Human
18
1995
329
4.290
Why?
Respiratory Syncytial Viruses
21
1990
125
4.160
Why?
Virus Diseases
9
1991
82
3.920
Why?
Reverse Transcriptase Polymerase Chain Reaction
18
2001
513
3.720
Why?
Aged
66
1990
6986
2.770
Why?
Aged, 80 and over
36
1992
2423
2.160
Why?
Pulmonary Disease, Chronic Obstructive
6
2005
101
2.000
Why?
Influenza Vaccines
6
2007
239
1.960
Why?
Nasal Mucosa
8
1999
56
1.860
Why?
Antigens, Viral
10
1995
151
1.850
Why?
Influenza A virus
9
1999
222
1.770
Why?
Molecular Diagnostic Techniques
3
2010
10
1.770
Why?
Sputum
3
2007
38
1.720
Why?
Humans
88
1990
35000
1.680
Why?
Antiviral Agents
7
1996
181
1.660
Why?
Viruses
4
1992
27
1.640
Why?
Virology
2
2011
22
1.580
Why?
Adult
43
1997
10906
1.490
Why?
Nursing Homes
9
1990
198
1.450
Why?
Hospitalization
10
1995
354
1.400
Why?
Middle Aged
36
1990
9461
1.360
Why?
Pneumonia, Viral
4
2005
28
1.360
Why?
Immunoenzyme Techniques
8
1990
220
1.350
Why?
Neutralization Tests
7
1997
128
1.280
Why?
Male
46
1992
18870
1.270
Why?
Female
47
1990
19061
1.260
Why?
Specimen Handling
3
1999
70
1.240
Why?
Viral Vaccines
7
1996
107
1.240
Why?
Antibodies, Neutralizing
4
2009
31
1.180
Why?
Respiratory Syncytial Virus Vaccines
4
2007
13
1.100
Why?
HN Protein
4
1998
37
1.030
Why?
Sensitivity and Specificity
11
1996
866
0.980
Why?
Coronavirus Infections
4
1999
15
0.950
Why?
Disease Outbreaks
2
2003
109
0.940
Why?
Prospective Studies
16
1992
1606
0.940
Why?
Inpatients
4
2002
69
0.890
Why?
Immunoglobulin G
12
1997
491
0.870
Why?
Day Care
3
1995
14
0.860
Why?
Coronavirus
3
1997
10
0.860
Why?
Viral Envelope Proteins
6
1998
90
0.830
Why?
Respiratory Insufficiency
2
2008
56
0.820
Why?
Pneumonia, Bacterial
1
2012
15
0.800
Why?
Calcitonin
1
2012
41
0.790
Why?
Homes for the Aged
6
1992
60
0.770
Why?
Protein Precursors
1
2012
82
0.770
Why?
Respiratory Tract Diseases
2
2010
44
0.730
Why?
Bacterial Infections
1
2012
127
0.730
Why?
Immunity, Humoral
2
2009
18
0.730
Why?
Viral Proteins
6
1998
216
0.710
Why?
Immunization
2
2001
153
0.710
Why?
Drug Delivery Systems
1
2010
59
0.690
Why?
Pneumonia
1
2012
188
0.680
Why?
RNA, Viral
4
2001
274
0.680
Why?
Frail Elderly
5
1995
60
0.680
Why?
Glucocorticoids
1
2011
159
0.680
Why?
New York
9
1990
1191
0.660
Why?
Alum Compounds
1
2008
5
0.640
Why?
Nasopharynx
3
1997
46
0.610
Why?
Influenza B virus
1
2007
43
0.550
Why?
Seasons
7
1990
92
0.540
Why?
Antibody-Producing Cells
3
2010
37
0.540
Why?
Rhinovirus
4
1991
18
0.530
Why?
Risk Factors
7
1992
2172
0.520
Why?
DNA, Viral
1
2007
288
0.500
Why?
Common Cold
2
1999
10
0.500
Why?
Vaccination
6
1996
197
0.480
Why?
Diagnosis, Differential
4
2003
855
0.460
Why?
Virus Shedding
1
2003
10
0.450
Why?
Viral Load
3
2003
138
0.450
Why?
Heart Failure
2
1999
337
0.450
Why?
Immunoglobulin A, Secretory
2
1999
23
0.440
Why?
HSP90 Heat-Shock Proteins
1
2003
17
0.440
Why?
Severe Acute Respiratory Syndrome
1
2003
6
0.440
Why?
C-Reactive Protein
2
2001
118
0.430
Why?
Long-Term Care
3
2005
59
0.420
Why?
Aging
3
1999
692
0.420
Why?
Respirovirus Infections
3
1990
65
0.420
Why?
Cholecystitis
1
2002
8
0.420
Why?
Stress, Physiological
1
2003
102
0.410
Why?
Immunoglobulin A
3
2000
88
0.390
Why?
Interferon-gamma
3
2005
340
0.390
Why?
Nose
3
1996
44
0.380
Why?
Staphylococcal Infections
1
2002
103
0.380
Why?
Double-Blind Method
5
1996
985
0.380
Why?
Staphylococcus aureus
1
2002
108
0.380
Why?
Apolipoproteins
1
2001
41
0.370
Why?
Antibody Formation
4
1992
176
0.370
Why?
Cross Infection
3
1991
85
0.370
Why?
Heart Diseases
3
2002
132
0.370
Why?
Vaccines, Synthetic
2
1997
89
0.360
Why?
Cohort Studies
5
1995
912
0.360
Why?
Vaccines, Attenuated
1
2000
82
0.350
Why?
Lung Diseases
3
2002
224
0.340
Why?
Pharynx
2
2007
31
0.330
Why?
Infection Control
1
1999
27
0.320
Why?
Adolescent
7
1999
4513
0.320
Why?
Age Factors
5
1999
1060
0.310
Why?
Logistic Models
2
2009
581
0.310
Why?
Young Adult
4
2008
1013
0.300
Why?
Disease Progression
2
2008
496
0.300
Why?
Acute Disease
7
1992
570
0.300
Why?
Interleukin-10
2
2005
99
0.290
Why?
Predictive Value of Tests
2
2007
579
0.290
Why?
Coronavirus 229E, Human
1
1997
3
0.290
Why?
Incidence
5
1990
644
0.290
Why?
Time Factors
4
2002
3047
0.290
Why?
Immunologic Memory
2
2005
132
0.290
Why?
Immunity, Mucosal
3
1999
25
0.290
Why?
Virus Cultivation
2
2003
30
0.290
Why?
Chlamydophila pneumoniae
2
1993
10
0.280
Why?
Fluorescent Antibody Technique, Indirect
2
1996
46
0.280
Why?
Severity of Illness Index
4
2007
878
0.280
Why?
Leukocytes, Mononuclear
3
2002
109
0.270
Why?
Child, Preschool
4
1991
2452
0.270
Why?
Asthma
2
2007
282
0.260
Why?
Biological Markers
3
2001
532
0.260
Why?
Dose-Response Relationship, Immunologic
2
2000
60
0.260
Why?
Respirovirus
2
2004
11
0.250
Why?
Immunocompromised Host
2
2000
84
0.240
Why?
Treatment Outcome
3
1995
2487
0.230
Why?
United States
4
2005
2511
0.220
Why?
Chlamydia Infections
1
1993
22
0.220
Why?
Cytokines
2
2002
555
0.220
Why?
Child
3
2006
3897
0.210
Why?
Panax
1
2012
1
0.200
Why?
Clinical Trials as Topic
2
1998
664
0.200
Why?
Plant Extracts
1
2012
21
0.200
Why?
National Institute on Aging (U.S.)
1
2011
1
0.200
Why?
T-Lymphocyte Subsets
2
1999
111
0.200
Why?
Multivariate Analysis
2
2001
487
0.190
Why?
CD4-Positive T-Lymphocytes
3
1999
299
0.190
Why?
Croatia
2
2006
3
0.190
Why?
Skilled Nursing Facilities
1
1991
21
0.190
Why?
Bystander Effect
1
2011
3
0.190
Why?
Adaptive Immunity
1
2011
9
0.190
Why?
Sendai virus
1
2011
19
0.190
Why?
Viral Fusion Proteins
2
1997
39
0.190
Why?
Infant
4
1991
2102
0.190
Why?
Chronic Disease
3
1997
496
0.190
Why?
AIDS Vaccines
1
2011
67
0.180
Why?
Injections, Intradermal
1
2010
15
0.180
Why?
Granzymes
1
2010
3
0.180
Why?
Injections, Intramuscular
1
2010
70
0.180
Why?
Statistics, Nonparametric
1
2011
251
0.180
Why?
Retrospective Studies
2
2005
2167
0.170
Why?
Up-Regulation
1
2012
344
0.170
Why?
Fasciitis
1
1990
11
0.170
Why?
Epitope Mapping
1
2010
28
0.170
Why?
Aspergillosis
1
1990
17
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2012
125
0.170
Why?
Evaluation Studies as Topic
2
1996
240
0.170
Why?
Outpatients
1
2009
29
0.170
Why?
Biomedical Research
1
2011
132
0.170
Why?
Surgical Wound Infection
1
1990
57
0.160
Why?
Epitopes
1
2010
200
0.160
Why?
Ribavirin
2
1996
45
0.160
Why?
Boston
1
2008
12
0.160
Why?
Flow Cytometry
1
2011
597
0.160
Why?
Phylogeny
1
2008
116
0.150
Why?
Risk Assessment
1
2012
808
0.150
Why?
Length of Stay
2
1995
284
0.150
Why?
Community-Acquired Infections
1
2007
27
0.140
Why?
Morbidity
1
2007
70
0.140
Why?
Communicable Disease Control
1
2007
24
0.140
Why?
Fever
2
2002
106
0.140
Why?
Communicable Diseases
1
2007
22
0.140
Why?
Anti-Bacterial Agents
2
2007
432
0.140
Why?
World Health
1
2007
59
0.140
Why?
Genotype
1
2008
455
0.140
Why?
Cell Culture Techniques
2
2003
86
0.140
Why?
Infant, Newborn
2
2006
1772
0.130
Why?
Health Services for the Aged
1
2007
57
0.130
Why?
Tumor Suppressor Protein p53
1
2007
134
0.130
Why?
Orthomyxoviridae
1
2006
57
0.130
Why?
Residence Characteristics
1
2005
65
0.120
Why?
Health Services
1
2005
59
0.120
Why?
Enzyme-Linked Immunosorbent Assay
2
1999
459
0.110
Why?
Seroepidemiologic Studies
2
1998
12
0.110
Why?
Cell Nucleus
1
2007
481
0.110
Why?
Protein S
1
2003
6
0.110
Why?
Hong Kong
1
2003
23
0.110
Why?
Causality
1
2003
43
0.110
Why?
Fluorescent Antibody Technique
1
2003
287
0.110
Why?
World Health Organization
1
2003
37
0.110
Why?
Gallbladder
1
2002
19
0.100
Why?
Cough
1
2002
22
0.100
Why?
Rimantadine
1
2002
10
0.100
Why?
Zanamivir
1
2002
13
0.100
Why?
Oseltamivir
1
2002
10
0.100
Why?
Pyrans
1
2002
14
0.100
Why?
Amantadine
1
2002
22
0.100
Why?
Guanidines
1
2002
32
0.100
Why?
Acetamides
1
2002
30
0.100
Why?
Sialic Acids
1
2002
33
0.100
Why?
Regression Analysis
2
2000
489
0.100
Why?
Glycoproteins
1
2003
189
0.100
Why?
Animals
4
1993
15647
0.100
Why?
Drug Resistance, Viral
1
2002
67
0.090
Why?
Convalescence
1
2001
19
0.090
Why?
Serum Amyloid A Protein
1
2001
22
0.090
Why?
Thrombophilia
1
2001
12
0.090
Why?
Cells, Cultured
3
1998
2367
0.090
Why?
Hemostatics
1
2001
23
0.090
Why?
Follow-Up Studies
1
2005
1757
0.090
Why?
Hepatitis B Vaccines
1
2001
26
0.090
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2001
79
0.090
Why?
Hemagglutination Inhibition Tests
2
2010
74
0.090
Why?
Adjuvants, Immunologic
1
2001
118
0.090
Why?
Lung Diseases, Obstructive
1
1999
42
0.080
Why?
Antibody Specificity
1
1999
104
0.080
Why?
Practice Guidelines as Topic
1
2002
288
0.080
Why?
Drug Administration Schedule
1
2000
362
0.080
Why?
Cytomegalovirus
1
1999
77
0.080
Why?
Cytomegalovirus Infections
1
1999
77
0.080
Why?
Antineoplastic Agents
1
2003
598
0.080
Why?
Prevalence
2
1990
530
0.070
Why?
Picornaviridae Infections
2
1991
11
0.070
Why?
Analysis of Variance
1
1999
705
0.070
Why?
Safety
1
1997
99
0.070
Why?
Neoplasms
1
2003
701
0.070
Why?
Cross-Sectional Studies
1
1999
627
0.070
Why?
Risk
1
1998
343
0.070
Why?
Health Personnel
1
1997
57
0.070
Why?
Serologic Tests
1
1996
22
0.070
Why?
Cell Line
2
1993
1554
0.070
Why?
Reproducibility of Results
1
1999
859
0.060
Why?
T-Lymphocytes
1
1999
546
0.060
Why?
Enterovirus
1
1995
24
0.060
Why?
Allied Health Personnel
1
1995
16
0.060
Why?
Confidence Intervals
2
1999
155
0.060
Why?
Environmental Microbiology
1
1993
4
0.060
Why?
Aerosols
1
1993
115
0.050
Why?
Coronaviridae Infections
1
1991
1
0.050
Why?
Adenovirus Infections, Human
1
1991
8
0.050
Why?
Disease Susceptibility
1
1992
77
0.050
Why?
Amino Acid Sequence
2
1998
1198
0.050
Why?
Africa
1
2011
8
0.050
Why?
Psychology
1
2011
35
0.050
Why?
Japan
1
2011
28
0.050
Why?
Sickness Impact Profile
1
2011
35
0.050
Why?
Immunity
1
1992
65
0.050
Why?
Europe
1
2011
74
0.050
Why?
Age of Onset
1
2011
120
0.050
Why?
Parainfluenza Virus 1, Human
1
2011
37
0.050
Why?
Cross Reactions
1
2011
110
0.050
Why?
Enzyme-Linked Immunospot Assay
1
2010
5
0.050
Why?
Fibrinogen
2
2001
149
0.050
Why?
Skin
1
1993
370
0.050
Why?
Population Surveillance
1
2011
120
0.050
Why?
Hep G2 Cells
1
2010
9
0.050
Why?
Immune System
1
2011
72
0.050
Why?
CD8-Positive T-Lymphocytes
2
1999
223
0.040
Why?
Kinetics
1
1993
1377
0.040
Why?
Debridement
1
1990
22
0.040
Why?
Molecular Sequence Data
2
1998
1993
0.040
Why?
Immunity, Cellular
1
2010
135
0.040
Why?
Case-Control Studies
2
2001
587
0.040
Why?
Influenza A Virus, H3N2 Subtype
1
2010
64
0.040
Why?
Necrosis
1
1990
99
0.040
Why?
Comorbidity
1
2011
365
0.040
Why?
Odds Ratio
1
2010
301
0.040
Why?
Genetic Vectors
1
2011
328
0.040
Why?
Phenotype
1
2011
727
0.040
Why?
Diabetes Mellitus, Type 1
1
1990
162
0.040
Why?
Antigens, Polyomavirus Transforming
1
2007
22
0.040
Why?
Nuclear Localization Signals
1
2007
19
0.040
Why?
beta Karyopherins
1
2007
14
0.040
Why?
Interleukin-5
1
2007
41
0.040
Why?
Phytohemagglutinins
1
2007
54
0.040
Why?
Pilot Projects
1
2008
426
0.040
Why?
Cytosol
1
2007
186
0.030
Why?
Active Transport, Cell Nucleus
1
2007
98
0.030
Why?
Interleukin-4
1
2007
160
0.030
Why?
B-Lymphocytes
1
2010
460
0.030
Why?
Polymerase Chain Reaction
1
2007
586
0.030
Why?
Administration, Intranasal
1
2004
62
0.030
Why?
Complement Inactivator Proteins
1
2003
14
0.030
Why?
Hemostasis
1
2003
61
0.030
Why?
Mice
1
1993
5900
0.020
Why?
Matched-Pair Analysis
1
2001
17
0.020
Why?
Hepatitis B Antibodies
1
2001
11
0.020
Why?
Fibrin Fibrinogen Degradation Products
1
2001
47
0.020
Why?
Interleukin-6
1
2003
314
0.020
Why?
Dendritic Cells
1
2002
110
0.020
Why?
Antigens, CD56
1
1999
16
0.020
Why?
Antigens, CD45
1
1999
39
0.020
Why?
HLA-DR Antigens
1
1999
49
0.020
Why?
Antigens, CD28
1
1999
34
0.020
Why?
Sex Factors
1
2001
561
0.020
Why?
Attachment Sites, Microbiological
1
1998
5
0.020
Why?
Disease Transmission, Infectious
1
1996
13
0.020
Why?
Blotting, Western
1
1998
617
0.020
Why?
Tumor Cells, Cultured
1
1998
871
0.020
Why?
Recurrence
1
1996
656
0.010
Why?
Antibodies, Monoclonal
1
1998
725
0.010
Why?
Base Sequence
1
1998
1681
0.010
Why?
Mutation
1
1998
1183
0.010
Why?

Visualizations


Falsey's Networks

Concepts
_
Co-Authors
_
Same Department